Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer

Medical Oncology

Volumn 28, Issue 2, 2011, Pages 447-454

  Hu, Shi Lian ^a   Huang, Da Bing ^a   Sun, Yu Bei ^a   Wu, Lei ^b   Xu, Wei Ping ^b   Yin, Shi ^a   Chen, Jiong ^a   Jiang, Xiao Dong ^a   Shen, Gan ^c  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b Anhui Evidence based Medicine Center   (China)

^c Cadre's Ward of Anhui PPC Hospital   (China)

Author keywords

CHFR gene; Gastric cancer; Methylation; Methylation specific PCR; Runx3 gene

Indexed keywords

MESSENGER RNA; ONCOPROTEIN; PROTEIN CHECKPOINT WITH FORKHEAD AND RING FINGER; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER INVASION; CLINICAL FEATURE; DNA SEQUENCE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METHYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR DIFFERENTIATION; TUMOR VOLUME;

EID: 85027940278     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9467-6     Document Type: Article

References (30)

1. JC Machado, et al. 2001 E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma Oncogene 20 1525 1528 11313896 10.1038/sj.onc.1204234 1:CAS:528:DC%2BD3MXis1Kltrs%3D (Pubitemid 32291203)
2. TL Lee, et al. 2002 Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma Clin Cancer Res 8 1761 1766 12060614 1:CAS:528:DC%2BD38Xlt1CrtLg%3D
3. WK Leung, et al. 2005 Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer Br J Cancer 92 2190 2194 15942635 10.1038/sj.bjc.6602636 1:CAS:528: DC%2BD2MXltVygtb8%3D (Pubitemid 40966256)
4. N Oue, et al. 2002 Distinct promoter hypermethylation of p16INK4a, CDH1, and RAR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas J Pathol 198 55 59 12210063 10.1002/path.1170 1:CAS:528: DC%2BD38Xns1Wiurs%3D (Pubitemid 34966207)
5. A Balmain 2002 Cancer: new-age tumour suppressors Nature 417 235 237 12015584 10.1038/417235a 1:CAS:528:DC%2BD38Xjs1agsbk%3D (Pubitemid 34534691)
6. TY Kim, et al. 2004 Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma Lab Invest 84 479 484 14968123 10.1038/labinvest.3700060 1:CAS:528:DC%2BD2cXmtF2itrk%3D (Pubitemid 41656475)
7. Y Jiang D Tong G Lou Y Zhang J Geng 2008 Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines Pathobiology 75 244 251 18580070 10.1159/000132385 1:CAS:528:DC%2BD1cXnvFChur4%3D (Pubitemid 351918429)
8. MM Subramaniam, et al. 2009 RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression Breast Cancer Res Treat 113 113 121 18256927 10.1007/s10549-008-9917-4 1:CAS:528:DC%2BD1cXhsFWrs7nE
9. N Nishida, et al. 2008 Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma Hepatology 47 908 918 18161048 10.1002/hep.22110 1:CAS:528:DC%2BD1cXktVOhs74%3D (Pubitemid 351449682)
10. QL Li, et al. 2002 Causal relationship between the loss of RUNX3 expression and gastric cancer Cell 109 113 124 11955451 10.1016/S0092-8674(02) 00690-6 1:CAS:528:DC%2BD38XjtVOntLs%3D (Pubitemid 34327521)
11. M Toyota, et al. 2003 Epigenetic inactivation of CHFR in human tumors Proc Natl Acad Sci USA 100 7818 7823 12810945 10.1073/pnas.1337066100 1:CAS:528:DC%2BD3sXlt1Wqsb4%3D (Pubitemid 36760053)
12. PG Corn, et al. 2003 Frequent hypermethylation of the 5′ CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer Carcinogenesis 24 47 51 12538348 10.1093/carcin/24.1.47 1:CAS:528:DC%2BD3sXitlCgtLo%3D (Pubitemid 36193194)
13. DM Scolnick TD Halazonetis 2000 Chfr defines a mitotic stress checkpoint that delays entry into metaphase Nature 406 430 435 10935642 10.1038/35019108 1:CAS:528:DC%2BD3cXlslKnu7c%3D (Pubitemid 30625565)
14. Sobin LH, Wittekind C. TNM classification of malignant tumors. 5th ed. International Union Against Cancer (UICC): New York; 1997.
15. JG Herman JR Graff S Myohanen BD Nelkin SB Baylin 1996 Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 93 9821 9826 8790415 10.1073/pnas.93.18.9821 1:CAS:528:DyaK28XlsFeht7Y%3D (Pubitemid 26296693)
16. Y Shibata, et al. 2002 Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer Carcinogenesis 23 1695 1699 12376479 10.1093/carcin/23.10.1695 1:CAS:528:DC%2BD38XnvF2qsbo%3D
17. N Homma, et al. 2006 Spreading of methylation within RUNX3 CpG island in gastric cancer Cancer Sci 97 51 56 16367921 10.1111/j.1349-7006.2005.00133.x 1:CAS:528:DC%2BD28Xht1Kqtrw%3D (Pubitemid 43257027)
18. YJ Gao Y Xin JJ Zhang J Zhou 2008 Mechanism and pathobiologic implications of CHFR promoter methylation in gastric carcinoma World J Gastroenterol 14 5000 5007 18763281 10.3748/wjg.14.5000 1:CAS:528: DC%2BD1cXhsVyntLvF
19. L Wang, et al. 2003 Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer Clin Cancer Res 9 6371 6380 14695137 1:CAS:528:DC%2BD3sXhtVSqurzK (Pubitemid 38031822)
20. F Sato SJ Meltzer 2006 CpG island hypermethylation in progression of esophageal and gastric cancer Cancer 106 483 493 16362978 10.1002/cncr.21657 1:CAS:528:DC%2BD28XhsFGiurg%3D (Pubitemid 43157610)
21. QC Lau, et al. 2006 RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer Cancer Res 66 6512 6520 16818622 10.1158/0008-5472.CAN-06-0369 1:CAS:528: DC%2BD28XmsVamtro%3D (Pubitemid 44085605)
22. JL Ku, et al. 2004 Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines Oncogene 23 6736 6742 15273736 10.1038/sj.onc.1207731 1:CAS:528:DC%2BD2cXntFGnurY%3D (Pubitemid 39280005)
23. G Tamura 2004 Promoter methylation status of tumor suppressor and tumor-related genes in neoplastic and non-neoplastic gastric epithelia Histol Histopathol 19 221 228 14702190 1:CAS:528:DC%2BD2cXjtFyrtbo%3D (Pubitemid 38111266)
24. T Honda, et al. 2004 Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia Br J Cancer 90 2013 2016 15138487 10.1038/sj.bjc.6601849 1:CAS:528:DC%2BD2cXjvVals7k%3D (Pubitemid 38746346)
25. T Waki, et al. 2003 Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia Cancer Sci 94 360 364 12824905 10.1111/j.1349-7006.2003.tb01447.x 1:CAS:528:DC%2BD3sXkslCns7w%3D (Pubitemid 36626369)
26. HC Kang, et al. 2004 Promoter hypermethylation and silencing of CHFR mitotic stress checkpoint gene in human gastric cancers Oncol Rep 12 129 133 15201973 1:CAS:528:DC%2BD2cXlvVeqsrs%3D
27. Y Morioka, et al. 2006 Aberrant methylation of the CHFR gene in digestive tract cancer Anticancer Res 26 1791 1795 16827108 1:CAS:528: DC%2BD28XntV2nsb4%3D (Pubitemid 43989433)
28. WJ Kim SC Bae 2008 Molecular biomarkers in urothelial bladder cancer Cancer Sci 99 646 652 18377416 10.1111/j.1349-7006.2008.00735.x 1:CAS:528:DC%2BD1cXlsFygu70%3D (Pubitemid 351448065)
29. EJ Kim, et al. 2008 Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor J Urol 180 1141 1145 18639281 10.1016/j.juro.2008.05.002 1:CAS:528:DC%2BD1cXhtVKmsbbL
30. LM Privette ME Gonzalez L Ding CG Kleer EM Petty 2007 Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression Cancer Res 67 6064 6074 17596595 10.1158/0008-5472.CAN-06- 4109 1:CAS:528:DC%2BD2sXnsVyqsb8%3D (Pubitemid 47037485)